An apparatus for the preparation and distribution of individual dosage units of pharmaceutical material including a portable housing means provided with a plurality of distribution trays removably mounted therein. Each of the trays include aligned rows of container-receiving recesses adapted to receive unit dose containers of pharmaceutical materials. Further, the trays include slot means disposed adjacent the container-receiving recesses for removably receiving identifying cards for each patien...

Disclosed are antirheumatic compositions containing therapeutically effective amounts of dimethyl aminophenazone and an alkali metal salt of 1-phenyl-4-n-butyl-3,5-dioxopyrazolidine in aqueous solution. The compositions can also contain effective amounts of Lidocaine and Dexamethasone. The compositions described are prepared by bringing together under agitated flow conditions dimethyl aminophenazone with water which contains an alkali metal salt of 1-phenyl-4-n-butyl-3,5-dioxopyrazolidine as a s...

Method for selective partial hydrolysis of steroid glycosides of 2-deoxysugar units, which comprises reacting glycol cleaving agents followed by optional reduction and mild hydrolysis, cardiotonic compounds of the formula: ##SPC1## Wherein R and R' each represents a hydrogen atom or hydroxyl group and n' is an integer of 1 or 2, and esters thereof, and pharmaceutical preparations containing the compounds or products of the process of the present invention.

An anaesthetic composition for use by intravenous injection containing a water-soluble steroidal anaesthetic and a parenterally acceptable non-ionic surface active agent.

There is provided a pharmaceutical composition in dosage unit form comprising (a) 1 - 100 mg. of glycyrrhetinic acid and/or of at least one anti-inflammatory active derivative thereof, in admixture with (b) 1 - 50% by weight of alginic acid and/or at least one non-toxic salt thereof and/or of at least one carboxyalkyl-cellulose and/or of at least one non-toxic salt thereof, (c) 1 - 30% by weight of at least one non-toxic carbonate and/or bicarbonate and (d) 0 - 30% by weight of at least one anta...

Complexes of a semi-synthetic penicillin and an anion exchange resin cross-linked less than 4% and wherein the penicillin, with or without a non-complexed additional penicillin, is absorbed onto and in the ducts or channels in the resin particles substantially all of which have diameters between 20 .mu. and 250 .mu.. The semi-synthetic penicillin constitutes 35-65% of the complex. The complexes are formulated as pharmaceutical compositions which can be in tablet or syrup form. The penicillin is ...

The present invention relates to new pharmaceutical compositions comprising an .alpha.-receptor blocker, a .beta.-receptor blocker and a pharmaceutical carrier and to a method of using said compositions in the treatment of high blood pressure and angina pectoris.

Improved pharmaceutical lubricants comprising finely divided magnesium or calcium stearate coated with a surfactant are disclosed. The improved lubricants greatly enhance disintegration and dissolution time of tablets and capsules prepared therefrom without loss in essential pharmaceutical lubricant properties.

This invention relates to a topical, anti-inflammatory, pharmaceutical composition which comprises (a) a pharmaceutically acceptable solvent, e.g. propylene glycol and water, and (b) at least two corticosteroids chosen from those represented by formulas A through K defined hereinafter, each corticosteroid dissolved in said solvent at a concentration equal to the saturation solubility for each steroid. Other suitable pharmaceutical formulation additives may be added to prepare the desired type of...

Pharmaceutical compositions containing the known compound dihydrocanadensolide; an improved process for the manufacture of dihydrocanadensolide; and a method of using dihydrocanadensolide in the treatment of ulcers in warm-blooded animals.